Literature DB >> 15221409

Anti-angiogenic effects of thalidomide: expression of apoptosis-inducible active-caspase-3 in a three-dimensional collagen gel culture of aorta.

Keiko Fujita1, Yoshiko Asami, Kayoko Tanaka, Masumi Akita, Hans-Joachim Merker.   

Abstract

The anti-angiogenic properties of thalidomide have led to the use of the agent as a remedy for multiple myeloma. Nevertheless, the anti-angiogenic moiety of thalidomide remains unidentified. In this study we examined the anti-angiogenic effects of thalidomide in an in vitro model using a three-dimensional collagen gel culture. Angiogenesis was significantly inhibited when the culture was treated with thalidomide plus cytochrome P-450 (CYP2B4), and the migrating cells and tubules were positive for active-caspase-3 in an accompanying immunohistochemical investigation. Transmission electron microscopic observation also confirmed that active-caspase-3-positive cells demonstrated apoptotic characteristics. This study is the first to morphologically demonstrate the effect of thalidomide in directly inducing the apoptosis of new tubules and migrating cells on a three-dimensional collagen gel culture of aorta. Taken together with earlier findings, our new results indicate that the thalidomide-induced inhibition of angiogenesis involves apoptosis in addition to the suppression of TNF-alpha and inhibition of cell migration from aorta explants, i.e., the factors important for capillarogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221409     DOI: 10.1007/s00418-004-0669-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  21 in total

1.  2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.

Authors:  Dong Cho Han; Mi-Young Lee; Ki Deok Shin; Sun Bok Jeon; Jung Min Kim; Kwang-Hee Son; Hyoung-Chin Kim; Hwan-Mook Kim; Byoung-Mog Kwon
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

2.  Effects of thalidomide, cytochrome P-450 and TNF-alpha on angiogenesis in a three-dimensional collagen gel-culture.

Authors:  Keiko Fujita; Yoshiko Asami; Eiko Murata; Masumi Akita; Katsuji Kaneko
Journal:  Okajimas Folia Anat Jpn       Date:  2002-10

3.  Formation of new capillary-like tubes in a three-dimensional in vitro model (aorta/collagen gel).

Authors:  M Akita; E Murata; H J Merker; K Kaneko
Journal:  Ann Anat       Date:  1997-04       Impact factor: 2.698

4.  Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.

Authors:  H Sauer; J Günther; J Hescheler; M Wartenberg
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

Authors:  Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Dharminder Chauhan; Paul G Richardson; Teru Hideshima; Nikhil C Munshi; Steven P Treon; Kenneth C Anderson
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

6.  Embryotoxicity in chick embryo of thalidomide hydrolysis products following metabolic activation by rat liver homogenate.

Authors:  D Veselá; D Veselý; R Jelínek
Journal:  Funct Dev Morphol       Date:  1994

Review 7.  Oxidative damage in chemical teratogenesis.

Authors:  P G Wells; P M Kim; R R Laposa; C J Nicol; T Parman; L M Winn
Journal:  Mutat Res       Date:  1997-12-12       Impact factor: 2.433

8.  Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent.

Authors:  K S Bauer; S C Dixon; W D Figg
Journal:  Biochem Pharmacol       Date:  1998-06-01       Impact factor: 5.858

9.  Thalidomide is an inhibitor of angiogenesis.

Authors:  R J D'Amato; M S Loughnan; E Flynn; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.

Authors:  K Dredge; J B Marriott; C D Macdonald; H-W Man; R Chen; G W Muller; D Stirling; A G Dalgleish
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

View more
  8 in total

Review 1.  Recent progress in histochemistry and cell biology: the state of the art 2005.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2005-11-11       Impact factor: 4.304

2.  An in vitro model for studying vascular injury after laser microdissection.

Authors:  Keiko Fujita; Kumiko Komatsu; Kayoko Tanaka; Susumu Ohshima; Yoshiko Asami; Eiko Murata; Masumi Akita
Journal:  Histochem Cell Biol       Date:  2005-11-16       Impact factor: 4.304

Review 3.  Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.

Authors:  Xiubao Chang; Yuanxiao Zhu; Changxin Shi; A Keith Stewart
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-12-29       Impact factor: 3.848

4.  A framework to identify gene expression profiles in a model of inflammation induced by lipopolysaccharide after treatment with thalidomide.

Authors:  Renata T Paiva; Alessandra M Saliba; Tatiana O Fulco; Jorgenilce de Souza Sales; Daniel Serra de Carvalho; Elizabeth P Sampaio; Ulisses G Lopes; Euzenir N Sarno; Flavio F Nobre
Journal:  BMC Res Notes       Date:  2012-06-13

Review 5.  News and views in Histochemistry and Cell Biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2004-12-22       Impact factor: 2.531

6.  Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.

Authors:  K P Tamilarasan; Gopi Krishna Kolluru; Megha Rajaram; M Indhumathy; R Saranya; Suvro Chatterjee
Journal:  BMC Cell Biol       Date:  2006-04-04       Impact factor: 4.241

7.  A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma.

Authors:  Teru Hideshima; Noopur Raje; Paul G Richardson; Kenneth C Anderson
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

8.  Detection of the Hematopoietic Stem and Progenitor Cell Marker CD133 during Angiogenesis in Three-Dimensional Collagen Gel Culture.

Authors:  Masumi Akita; Kayoko Tanaka; Sachiko Matsumoto; Kumiko Komatsu; Keiko Fujita
Journal:  Stem Cells Int       Date:  2013-06-23       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.